Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRX✓SelectedUSD · RRXGSK vs RRX performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs RRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
RRX return
+5.1%
Excess return
+41.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioRRXExcessAlpha
1D-0.1%-4.2%+4.1%+0.2%
7D-1.3%-6.5%+5.2%-0.9%
30D+2.7%+9.7%-7.0%+2.0%
3M+2.7%-3.5%+6.2%+2.8%
6M+3.3%-14.0%+17.3%+3.7%
YTD+6.5%+21.1%-14.7%+4.0%
1Y+10.7%+24.0%-13.4%+7.9%
3Y+64.4%+50.8%+13.5%+55.4%
5Y+46.7%+3.6%+43.0%+41.1%
All+46.7%+5.1%+41.6%+41.1%

Cumulative growth

Daily Returns

Daily percentage return beside RRX.

Daily Out/Under-Performance

Portfolio return minus RRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded RRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling